KIAA1429 mediates epithelial mesenchymal transition in sorafenib‐resistant hepatocellular carcinoma through m6A methylation modification

BACKGROUND: Hepatocellular carcinoma (HCC) is a primary liver cancer with high mortality. The long‐term use of sorafenib, a targeted drug for hepatocellular carcinoma, will lead to drug resistance, and patients are prone to cancer metastasis, the molecular mechanism of which is still unclear. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Ye, Cheng, Yun, Wang, Jia, Li, Hongyan, Cao, Xianghong, Wang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067093/
https://www.ncbi.nlm.nih.gov/pubmed/36420693
http://dx.doi.org/10.1002/cam4.5432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067093/
https://www.ncbi.nlm.nih.gov/pubmed/36420693
http://dx.doi.org/10.1002/cam4.5432

Ejemplares similares